ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "ACPA"

  • Abstract Number: 449 • 2014 ACR/ARHP Annual Meeting

    Citrullinated-Vimentin-Specific Regulatory T-Cell Responses Associate with ACPA Positive Individuals with Non-Specific Musculoskeletal Symptoms

    Aamir Aslam1, Jackie L. Nam1, Laura Hunt1, Chadi Rakieh1, Ann W. Morgan2 and Paul Emery1, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

    Background/Purpose: The pathogenesis of RA can be conceptualised by sequential phases that precede the development of synovitis.  Autoimmune antibody responses, including ACPA, can precede clinical…
  • Abstract Number: 2019 • 2014 ACR/ARHP Annual Meeting

    Antibodies to Citrullinated Clusterin, Filaggrin, Vimentin, and Fibrinogen Are Associated with Blood Pressure in First-Degree Relatives of Rheumatoid Arthritis Patients: The Studies of the Etiology of Rheumatoid Arthritis

    Jan M. Hughes-Austin1, Ryan W. Gan2, Kevin D. Deane3, Peter K. Gregersen4, Michael H. Weisman5, Joachim H. Ix6, Jeremy Sokolove7, William H. Robinson8, V. Michael Holers9 and Jill M. Norris2, 1Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, 2Epidemiology, Colorado School of Public Health, Aurora, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 4The Feinstein Institute for Medical Research, Manhasset, NY, 5Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, 6University of California, San Diego, La Jolla, CA, 7VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 8VA Palo Alto Health Care System and Stanford University, Palo Alto, CA, 9Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose Hypertension is common in rheumatoid arthritis (RA), but it is unclear whether this prevalence is due to RA-related medications or to the disease process…
  • Abstract Number: 448 • 2014 ACR/ARHP Annual Meeting

    Citrulline-Specific Autoimmunity Resides in Quiescent Circulating Memory B Cells in Rheumatoid Arthritis

    Adam Pelzek, Caroline Grönwall, Jeffrey D. Greenberg and Gregg J. Silverman, Medicine, New York University School of Medicine, New York, NY

    Background/Purpose . The detection of anti-citrullinated protein antibodies (ACPA) aids RA diagnosis, while B cell depletion by anti-CD20 can provide clinical benefits. We therefore undertook…
  • Abstract Number: 1740 • 2014 ACR/ARHP Annual Meeting

    Predicting the Evolution of Inflammatory Arthritis in ACPA-Positive Individuals: Can T-Cell Subsets Model Help?

    Laura Hunt1, Agata Burska2, Elizabeth M.A. Hensor1, Jackie L. Nam1, Frederique Ponchel1 and Paul Emery1, 1NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 2NIHR-Leeds Musculoskeletal Biomedical Research Unit and Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds., Leeds, United Kingdom

    Background/Purpose: ACPA+ individuals with non-specific musculoskeletal symptoms are at high risk of developing rheumatoid arthritis (RA). We previously demonstrated dys-regulation of T-cell subsets with loss…
  • Abstract Number: 447 • 2014 ACR/ARHP Annual Meeting

    Rheumatoid Factor Isotypes in Relation to Antibodies Against Citrullinated Peptides in Individuals before Onset of Rheumatoid Arthritis

    Mikael Brink1, Monika Hansson2, Linda Mathsson-Alm3, Johan Rönnelid3, Lars Klareskog2 and Solbritt Rantapää-Dahlqvist4, 1Public Health & Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden, 2Department of Medicine, Rheumatology Unit, Karolinska Institute, Stockholm, Sweden, 3Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 4Public Health & Clinical Medicine/Rheumatology, Institution of Public health and clinical medicine/ Rheumatology, University of Umeå, Rheumatology, Sweden, Umeå, Sweden

    Background/Purpose The presence of rheumatoid factor (RF) and antibodies against citrullinated peptides (ACPA) has been shown to precede the development of rheumatoid arthritis (RA) by…
  • Abstract Number: 1786 • 2013 ACR/ARHP Annual Meeting

    91% Of Early RA Patients Are Positive For Serum 14-3-3η Or Its Auto-Antibodies

    Walter P. Maksymowych1, Dirkjan van Schaardenburg2, Désirée van der Heijde3, Robert Landewé4, Gilles Boire5, Maarten Boers6, Vivian P. Bykerk7, Edward C. Keystone8, Katherine A. Siminovitch9, Mairead Murphy10 and Anthony Marotta11, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Jan van Breemen Research Institute | Reade, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 3Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 4Int Med/Rheumatology, Academic Medical Center, Amsterdam, Netherlands, 5Rheumatology Division, Centre Hospitalier Universitaire de Sherbrooke, Université de Sherbrooke, Sherbrooke, QC, Canada, 6Epidemiology & Biostatistics, VU University Medical Center, Amsterdam, Netherlands, 7Rheumatology, Hospital for Special Surgery, Weill Cornell Medical College, New York, NY, 8Department of Medicine, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 9Mount Sinai Hospital, Toronto, ON, Canada, 10Augurex Life Sciences Corp., North Vancouver, BC, Canada, 11Augurex Life Sciences Corp, North Vancouver, BC, Canada

    Background/Purpose: Current serological markers such as RF and ACPA are useful for early diagnosis and perhaps for screening people at risk, but there remains a…
  • Abstract Number: 177 • 2013 ACR/ARHP Annual Meeting

    Differences and Overlap Of Immunological Pathways Implicated In The Aetiology Of Anti-Citrullinated Peptide Antibody Positive and Negative Rheumatoid Arthritis

    Sebastien Viatte1, Paul Martin2, Andrew Brass3, Mark Lunt4, Anne Barton5 and Stephen Eyre5, 1Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 2Arthritis Research UK Epidemiology Unit, Manchester Academic Health Sciences Centre, Institute of Inflammation and Repair, The University of Manchester, Manchester, United Kingdom, 3School of Computer Science, University of Manchester, Manchester, United Kingdom, Manchester, United Kingdom, 4Arthritis Research UK Centre for Epidemiology, University of Manchester, Manchester, United Kingdom, 5Arthritis Research UK Epidemiology Unit, University of Manchester, Manchester, United Kingdom

    Background/Purpose: Genome-wide association studies have been successful in identifying single nucleotide polymorphisms (SNPs) associated with disease. However, previous studies have been under-powered to detect differences…
  • Abstract Number: 1421 • 2013 ACR/ARHP Annual Meeting

    Treatment Responses and Their Predictors Of Abatacept In Biologic naïve Patients With Rheumatoid Arthritis; Data Form Abroad Study

    Yutaka Kawahito1, Takao Fujii2, Akira Yokota3, Hideo Hashimoto4, Kiyoshi Matsui5, Kenji Miki6, Masayasu Kitano5, Naoki Shinmyo7, Aihiro Yamamoto1, Koichiro Ohmura8, Takanori Kuroiwa9, Toshihiko Hidaka10, Ichiro Yoshii11, Hideko Nakahara12, Takashi Fujimoto13, Kosaku Murakami14, Satoshi Morita15, Masahiro Sekiguchi5, Norihiro Nishimoto16,17, Tsuneyo Mimori8 and Hajime Sano5, 1Department of Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2Department of the Control for Rheumatic Diseases, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 3Yokota Clinic for Rheumatology, Osaka, Japan, 4Dept of Orthopedic Surgery, Rinku Hashimoto Rheumatology Orthopaedics, Osaka, Japan, 5Division of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya-city, Japan, 6Department of Orthopaedic Surgery, Amagasaki Central Hospital, Amagasaki, Japan, 7Kashiba Asahigaoka Hospital, Kashiba, Japan, 8Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Kyoto, Japan, 9Department of Rheumatology, Yukioka Hospital, Osaka, Japan, 10Zenjinkai Shimin-No-Mori Hospital, Miyazaki, Japan, 11Department of Orthopaedic Surgery, Yoshii Hospital, Shimanto, Japan, 12Division of Allergy, Rheumatology and Connective Tissue Diseases, Department of Internal Medicine, NTT West Osaka Hospital, Osaka, Japan, 13Nara Medical University, Kashihara, Japan, 14Rheumatology and Clinical Immunology, Osaka Red Cross Hospital, Osaka, Japan, 15Graduate School of Medicine & Medical Center, Department of Biostatistics and Epidemiology, Yokohama City University, Kanagawa, Japan, 16Tokyo Medical University, Tokyo, Japan, 17Osaka Rheumatology Clinic, Osaka, Japan

    Background/Purpose:  The identification of predictors of good response to biologic therapy is needed in the perspective of personalized medicine. To determine the predicting factors of efficacy…
  • Abstract Number: 2819 • 2013 ACR/ARHP Annual Meeting

    Administration Of a Multi-Epitope Citrullinated Peptide Attuneuates adjuvant  Induced Arthritis In Rats Via Induction Of Immune Tolerance

    Howard Amital1, Smadar Gertel2 and Yehuda Shoenfeld3, 1The Zabludowicz Center For Autoimmune Diseases, and Department of Medicine 'B',, Sheba Medical Center,Tel-Hashomer, Tel-Aviv University, Tel-hashomer, Israel, 2The Zabludowicz Center For Autoimmune Diseases, and Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel, 3Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel

    Background/Purpose: Antigen-induced peripheral tolerance is a potentially efficient and specific therapeutic approach to attenuate autoimmunity. Citrullinated peptides are major targets of disease-specific autoantibodies in Rheumatoid…
  • Abstract Number: 1389 • 2013 ACR/ARHP Annual Meeting

    Serum 14-3-3η Precedes and Independently Predicts The Development Of RA

    Dirkjan van Schaardenburg1, Reetinder Dhaliwal1, Walter P. Maksymowych2 and Anthony Marotta3, 1Jan van Breemen Research Institute | Reade, Jan van Breemen Research Institute | Reade, Amsterdam, Netherlands, 2Medicine, University of Alberta, Edmonton, AB, Canada, 3Augurex Life Sciences Corp, North Vancouver, BC, Canada

    Background/Purpose: We have previously reported on a risk prediction rule for the development of rheumatoid arthritis (RA) in 374 seropositive (RF and/or ACPA) arthralgia patients,…
  • Abstract Number: 2659 • 2013 ACR/ARHP Annual Meeting

    Antibodies To Citrullinated Enolase, Fibrinogen, and Vimentin Are Associated With Markers Of Endothelial Dysfunction In First-Degree Relatives Of Patients With Rheumatoid Arthritis: The Studies Of The Etiology Of Rheumatoid Arthritis

    Jan M. Hughes-Austin1, Kendra A. Young2, Kevin D. Deane3, Michael H. Weisman4, Jane H. Buckner5, Ted R. Mikuls6, James R. O'Dell7, Richard M. Keating8, Peter K. Gregersen9, Jeremy Sokolove10, William H. Robinson11, V. Michael Holers12 and Jill M. Norris2, 1Department of Family and Preventive Medicine, University of California, San Diego, La Jolla, CA, 2Epidemiology, Colorado School of Public Health, Aurora, CO, 3Division of Rheumatology, University of Colorado School of Medicine, Aurora, CO, 4Rheumatology, Cedars-Sinai Med Ctr, Los Angeles, CA, 5Benaroya Research Institute at Virginia Mason, Seattle, WA, 6Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE, 7Dept of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, 8Rheumatology Section, The University of Chicago, Chicago, IL, 9Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 10VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 11Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 12Rheumatology Division, University of Colorado School of Medicine, Aurora, CO

    Background/Purpose: Among rheumatoid arthritis (RA) patients, antibodies to citrullinated protein antigens (ACPA) have been detected in atherosclerotic plaques. In particular, antibodies to citrullinated fibrinogen (cit-fib)…
  • Abstract Number: 1396 • 2013 ACR/ARHP Annual Meeting

    Survivin–positivity Increases Risk For RA and Has a Strong Additive Effect On The Shared Epitope Alleles and Antibodies To Citrullinated Peptides In Patients Of The Malaysian Epidemiological Investigation Of Rheumatoid Arthritis (MyEIRA) Study Group

    Chun Lai Too1, Shahnaz Murad2, Malin Erlandsson3, Heselynn Hussein4, Wahinuddin Sulaiman5, Jasbir Singh Dhaliwal1 and Maria Bokarewa3, 1Institute for Medical Research, Allergy and Immunology Research Center, Jalan Pahang, Kuala Lumpur, Malaysia, 2Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia, 3Rheumatology and Inflammation Research, University of Gothenburg, Gothenburg, Sweden, 4Department of Medicine, Putrajaya Hospital, Putrajaya, Malaysia, 5Department of Medicine, Tengku Bainun Hospital, Ipoh, Perak, Malaysia

    Background/Purpose: The human leukocyte antigen (HLA)-DRB1 with alleles that contain common amino acid motif QKRAA termed shared epitope (SE) confer the major locus of genetic…
  • Abstract Number: 2432 • 2013 ACR/ARHP Annual Meeting

    Characterization Of Lung Inflammation and Identification Of Shared Citrullinated Targets In The Lungs and Joints Of Early RA

    Vijay Joshua1, Gudrun Reynisdottir2, Jimmy Ytterberg1, Marianne Engström2, Anders Eklund3, Magnus Skold3, Per-Johan Jakobsson4, Johan Rönnelid5, Vivianne Malmström6, Lars Klareskog4, Johan Grunewald3 and Anca I Catrina4, 1Medicine, Rheumatology Unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden, 2Department of Medicine, Rheumatology unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, 3Department of Medicine, Division of Respiratory Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, 4Medicine, Rheumatology unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, 5Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden, 6Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: To investigate if lung changes are present in rheumatoid arthritis (RA) patients early in the disease process and to address the contribution of these…
  • Abstract Number: 1319 • 2013 ACR/ARHP Annual Meeting

    Diagnostic Value Of Anti-Citrullinated Proteins Antibodies In Rheumatoid Arthritis

    Claudia L. Giraldo1, Rafael Chaparro del Moral2, Mercedes Ciancio3,4, Oscar L. Rillo5, Emilia Saint Martin6, Emilce Schneeberger7, Gustavo Citera7, Federico Zazzetti8, Amalia Schiel9 and Juan C. Barreira10, 1Rheumatology, Hospital Gral. de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 2Rheumatology Section, Hospital General de Agudos Dr. E. Tornú, Buenos Aires, Argentina, 3Hospital General de Agudos "Dr. E. Tornú", Buenos Aires, Argentina, 4Biochemestry, Buenos Aires, Argentina, 5Rheumatology, Hospital General de Agudos "Dr. E. Tornú", Buenos Aires, Argentina, 6Rheumatology, Instituto de Rehabilitacion Psicofisica, Buenos Aires, Argentina, 7Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 8Rheumatology, Buenos Aires Hospital Britanico, Buenos Aires, Argentina, 9Central Laboratory, British Hospital, Buenos Aires, Argentina, 10Rheumatology, Buenos Aires British Hospital, Buenos Aires, Argentina

    Background/Purpose: Citrulline and vimentin are some of the proteins used as antigens for anti-citrullinated proteins antibodies (ACPAs) detection for the diagnosis of rheumatoid arthritis (RA).…
  • Abstract Number: 2430 • 2013 ACR/ARHP Annual Meeting

    Antibodies To Porphyromonas Gingivalis as An Etiological Clue To The Development Of Anti-Citrullinated Protein Antibody Positive Rheumatoid Arthritis

    Nastya Kharlamova1, Natalia Sherina1, Anne-Marie Quirke2, Kaja Eriksson3, Lena Israelsson4, Jan Potempa5, Patrick Venables6, Tulay Yucel-Lindberg3 and Karin Lundberg7, 1Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 2University of Oxford, Kennedy Institute of Rheumatology, Oxford, United Kingdom, 3Department of Dentistry, Karolinska Institutet, Stockholm, Sweden, 4Medicine, Rheumatology unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden, 5Microbiology Department, Jagiellonian University, Krakow, Poland, 6Kennedy Institute of Rheumatology, Oxford, United Kingdom, 7Rheumatology unit, Karolinska University Hospital, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Rheumatoid arthritis (RA) is characterized by the production of autoantibodies to citrullinated proteins (ACPA). Citrullinated proteins are generated by the actions of peptidyl arginine…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology